HIF1A and COVID-19: Modulation of Akt/mTOR/HIF-1 pathway. Our data indicate a role of Akt/mTOR/HIF-1 in the cellular response to the SARS-CoV-2 infection, suggesting that drugs blocking this pathway could possibly be repurposed for COVID-19 patients.